Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.43 |
| ▸ | CYSLTR2 | Q9NS75 | 3/20 | 0.37 |
| ▸ | CYSLTR1 | Q9Y271 | 3/20 | 0.37 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | NCF1 | P14598 | 1/20 | 0.34 |
| ▸ | NOS2 | P35228 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6607250 | 0.83 | MEN1 (0.51) | MEN1MAPTKMT2AHDAC1HDAC8 | |
| SCHEMBL12933385 | 0.77 | MEN1 (0.51) | MEN1MAPTKMT2AHDAC1HDAC8 | |
| SCHEMBL28628097 | 0.74 | MEN1 (0.56) | MEN1MAPTKMT2AHDAC1HDAC8 | |
| SCHEMBL6600702 | 0.74 | MEN1 (0.56) | MEN1MAPTKMT2AHDAC1HDAC8 | |
| SCHEMBL24599908 | 0.72 | AGXT (0.50) | MEN1MAPTKMT2ACYP1A2CYP2C19 | |
| SCHEMBL9663555 | 0.71 | MAPT (0.61) | MEN1MAPTKMT2AHDAC1HDAC8 | |
| SCHEMBL5255451 | 0.71 | MAPT (0.46) | MEN1MAPTKMT2AHDAC1HDAC8 | |
| SCHEMBL2540903 | 0.71 | SMN1; SMN2 (0.46) | MEN1MAPTKMT2AHDAC1HDAC8 | |
| SCHEMBL31325635 | 0.71 | SMN1; SMN2 (0.46) | MEN1MAPTKMT2AHDAC1HDAC8 | |
| SCHEMBL31531064 | 0.71 | MEN1 (0.56) | MEN1MAPTKMT2AHDAC1HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220213039-A1 | PYRIDINIUM SALTS AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2022-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220213039-A1 | PYRIDINIUM SALTS AND PEST CONTROL AGENT | ZYX, PNPO, PRDX1 | MEN1 1530/4885MAPT 3721/4885KMT2A 913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.